Pricing Log in Create free account

Prima BioMed Ltd (IMMP) vs Polyrizon Ltd. (PLRZ)

Prima BioMed Ltd and Polyrizon Ltd. are both Biotechnology companies. Prima BioMed Ltd and Polyrizon Ltd. are of similar size ($23.7M and $23.7M). Across the 5 metrics below, Polyrizon Ltd. leads on 4 and Prima BioMed Ltd on 1.

Valuation

Metric IMMP PLRZ Biotechnology median
P/E n/m — 8.50
P/S n/m — 9.71
P/B 0.05 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (40.42%) — (33.15%)
Free cash flow yield (1,275.20%) 0.00% (25.50%)

Profitability

Metric IMMP PLRZ Biotechnology median
Gross margin — — 65.16%
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (56.36%)
Return on assets 0.00% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMMP PLRZ Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (33.84%) 99.37% 30.26%
Revenue growth, 5-year CAGR 40.79% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IMMP PLRZ Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.97 36.37 4.72
Net debt to EBITDA 0.92 2.11 0.96

Dividend

Metric IMMP PLRZ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMMP PLRZ Biotechnology median
Market cap 23.66m 23.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack